| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.47 | 0.09 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |